《实用免疫细胞与核酸》 参考文献

1．郭定九易凡，译.皮肤免疫病理学.1980年,长沙

2.SerreG, Viocent C , et al. Natural IgM and Igg autoantibodies to epidermal keratinsin normal human sera：I ELISA titration immunofluorecence study. J Invest Dermatol, 1987, 88：21～27

3.王刚,等.抗角蛋白自身抗体的研究进展．国外医学(皮肤病学分册),1982,18(2)：74

4.聂祝湘,等.天疱疮抗体及其临床意义.临床皮肤病科杂志,1991,20(6)：317～319

5. 聂祝湘,等.天疱疮治疗的某些进展.国外医学(皮肤病学分册),1991, 17(5)：265～268

6.ThompsonC, et al. Expression of blood group antigen by cultured human epidermal cells.J Invest Dermatol, 1986, 86：394～398

7.jANdBos. sis . keratinocyte p 75, CTC Press, Inc . Florida AM, 1989

8. 白兆霞,等.尖锐湿疣病损的免疫组化研究.中华皮肤科杂志,1992, 25：247

9.赵玉铭,等.HLA抗原在正常皮肤中的分布.中华皮肤科杂志,1991, 23(6)：402

10. VanLis JM , et al. Cin- Areaction with plasma membrane in human epidermsi. Am JClin Pathol, 1983, 779(1)：143～4

11.Hashimoto K, etal. A Lectin – binding glyciprotein of Mr 135000 associated withbasal keratinocyte in pig epidermis. Biochem J, 1986,237(2)：405～414

12.唐书谦,等.不同底物对大疱性皮肤病间接免疫荧光的评价评价.中华皮肤科杂志,1988,22(1)：36

13. 刘荣卿,等.天疱疮及大疱性类天疱疮外观正常皮肤的免疫荧光检查.中华皮肤科杂志,1987,20：138

14. 聂祝湘,等.止血芳酸治疗天疱疮的实验观察.中华皮肤科杂志,1992, 25(4)：256～258

15. WickMR and Scheithauer. Primary neuroendocrine carcinoma of the skin. In ：Pathology oof Unsual MalignantCutaneous Tumors. Wick MR ed. Ne W Yorh. Marcel Dekker INC, 1985. 107

16.Narisawa Y, Hashimoto K, Bayless T, et al. Cytokeratin polypeptide Profile ofmerkel cells in human fetal and adult skin：difference of expression of cytokeratins inepidermal and dermal merkle cells. j Invest Dermatol, 1992, 98：171

17.Narisawa Y , Hashimoto K, Nihei Y, et al. Biological significance of dermalmerkle cells in development of cutaneous nerves in human fetal skin. J HistchemCytochem, 1992；40：65

18. 刘荣卿唐书谦徐洁芳,等.天疱疮及大疱性类天疱疮外观正常皮肤的免疫荧光检查.中华皮肤科杂志,1987,20(3)：138～140

19. 刁庆春刘荣卿唐书谦.天疱疮、类天疱疮自身抗体检测的临床意义。中华皮肤科杂志，1988，21（5）：283

20．朱学骏niimi YJ Bystryn JC.大疱性类天疱疮抗原分子异质性。中华皮肤科杂志，1990，23：291～293

21．靳培英是元甫。疱疹样皮炎在我国的发病情况及其诊断标准的商榷.中华皮肤科杂志,1991,24(4)：232～235

22．Prost G, et al. Diagnosis of adultlinear IgA dermatosis by immuno ╟ electromicroscopy in 16 patients withlinear IgA deposits. J Invest Dermatol,1989, 92(1)：39～45

23.wojnarowska F, Marsden RA, Bhogal B, et al. Chronic bullous disease ofchildhood, childhood cicatricial pemphigoif, and linear Iga disease of adults.A comparative study demonsrating clinical and immunopathologic overlap. J AmAcad Dermatol, 1988, 19(5)：792～805

24. 朱学骏Niimi YJ Bystryn JC.抗基底膜带抗体阳性血清患者中获得性大疱性表皮松解症的发生率.临床皮肤科杂志,1990,19(4)：170～173

25.Akutsu Y and Jimbow K. Immunoelectron microscopic demonstration of humanmelanosome associated antigens (HMSA) on melanoma cells：Comparison with tyrosinasedistribution. J Invest Dermatol, 1988, 90：179

26.NakanishiT and Hashimoto K. The differential reactive of benign and malignantnevomelanecytic lesions with mouse monoclonal antibody TNKH1. Cancer, 1987, 50：1340

27. ImamA, Mitchell MS, Modlin RL, et al. Human monoclonal antibodies that distinguishcutaneous malignant melanomas form benign nevi in fixed Tissue sections. JInvest Dermatol, 1986, 86：145

28. GownAM, Vogel AM, Hoak M , et al. Monoclonan antibodies specific for melanocytictumors distinguish subpopulations of melanocytes. Am j Pathol, 1986, 123：195

29.Schaumburg - Lever G, Metzler G, Kaiserling E.Ultrastructural localization ofHMB –45 binding sites. J Cutan Pathol, 1991,18：432

30. 天高文叶庆佾刘荣卿.异常黑素小体在恶性黑素瘤诊断中的意义.第三军医大学学报,1992,14(4)：323

31.Furukawa K and Lloyd KO. Gangliosides in melanoma. IN：Human Melanoma. From Basicresearch to dinical application. Ferrone S ed. New York Springer –Verlag, 1990：15

32.Taniguchi M, Kuwabara I, Harada Y, et al. Cross ╟ species melanoma antigen. 1990.

33.Werkmeister JA, Triglia T, Mackay IR, et al. Fluctuations in the expression ofa glyolipid antigen assocted with differentiation of melanoma cells monitoredby a monoclonal antibody , Leo Me13. Cancer Res, 1987,47：225

34. 田芳金伯泉黄传书,等.抗人黑素瘤单克隆抗体免疫组化的研究.单克隆抗体通迅,1991,7：21

35. EstinCD, Plowman CD, Rose TM, et al. Characterization of P97, a humanmelanoma -associated antigen, and development of a recombinant vaccien formelanoma. In：Human Melanoma. From basic research to clinical application . FerroneSed. New York. Springer –Verlag, 1990.87

36.高天文刘荣卿叶庆佾.无色素性恶性黑素瘤免疫组化诊断研究.中华皮肤科杂志,1992, 25：222

37. 刘荣卿高天文.无色素性恶性黑素瘤的诊断探讨.实用肿瘤杂志,1992,7：152

38.NagataH, Ueki H, Moriguchi T, et al. Fibronectin,localization in normal human skin,granulation tissue, hypertropic scar, maure scar, progressive systemicsclerotic skin, and other fibrosing dermatoses. Arch Dermatol, 1985, 121(8)：995～999

39.Linares HA. Protroglycan – lymphocyte association in the development ofhypertrophic scars. Burns, 1990, 16(1)：21～24

40.Branchet MC, Boisnic S, Bletry O, et al. Exxpression of HLA class II antigensonskin fibroblasts in scleroderma. Br J Dermatol, 1992,12(5)：431～435

41.CastagnoliC, Stella M, Magliacani G, et al. Anomalous expression of HLA class IImolecules on kerattinocytes and fibroblasts in hypdrtropgicscars consequent tothermal injury. Clin Exp Immunol, 1990, 82(2)：350～354

42.Needleman BW, Increased expression of intercellular adhesion molecule 1 on thefibroblasts of scleroderma patientl. Arthritis Rheum,1990, 33(12)：1847～1851

43.Skalli U, Schurch W, Seemayer T, et al. Myofibrollasts from diverse pathologicsetting are heterogeneous in their content of actin isoforms and intermediatefilament proteins. Lab Invest, 1989, 60(2)：275

44.Sollberg S, Peltonen J, Uitto J, et al. Elevated expressoin of β２and β2integrins, intercellularadhesion molecule 1, and endothelial leukocyte adhesion molecule 1 in the skinof patients with sysytemic sclerosis of recent onset .Arthritis Rheum, 1992；35(3)：290～298

45. GayS, Jones RE, Huang GQ, et al. Immunohistologic demonstration of platelet -derives growth factor and sis – oncogene expression in scleroderma. J InvestDermatol, 1989, 92(2)：301～303

46.Klareskog L, Gustafsson R, Scheynius A, et al. Increased expression of platelet– derives growth factor type B receptors in the skin of patients with systemicsclerosis. Arthritis Rheum, 1990, 94(2)：197～203

47.Gruschwitz M, Muller PU, Sepp N, et al. Transcription and expression oftransforming growth factor type beta in the skin of progressive systemicsclerosis：amediator of fibrosis? J Invest Dermatol, 1990, 94(2)：197～203

48.Peltonen J, Hsiao LL, Jaakkola S, et al. Activation of collagengene expressionin keloids ：colocalization of type I and IV collagen and transforming growth factor–β1mRNA.J Invest Dermatol, 1991；97(2)：240～248

49.TraniAMA, Gruber BL, Kaufman LD, et al. Mast cell changes in scleroderma. ArthritisRheum, 1992；35(8)：933～939

50.Hashimoto K, et al. Anti – keratin monoclonal antibodies ：production, specificities andapplications. J Cutan Pathol, 1983；6(10)：529～539

51.KallioinenM, et al. β-2-microglobulin in benign and malignant adnexal skin tumors andmetastasizing basocellular carcinoma. J Cutan Pathol, 1984；1(11)：27～34

52.Penney NS. Immunohistochemistry of adnexal neoplasms. j Cutan Pathol , 1984；(11)：357～364

53.SwansonPE, et al. Eccrine sweat gland carcarcinoma：an histologic and immunohistochemical studyof 32 cases. J Cutan Pathol,1987,2(4)：65～86

54. NodaY, et al. Immunohistochemical study of carbonic anhydrase in mixed tumors andadenomas of sweat and sebaceous glands. J Cutan Pathol, 1987；5(14)：285～290

55.NodaY,et al. Immunohistochemical localization by monoclonal antibody of humanepidermal growth factor in mixed tumors of the skin. J Cutan Pathol, 1987；6(14)：337～342

56. ZukJA, et al. Immunohistochemistry staining patterns of sweat glands and theirneoplasms using two nomoclonal antibodies to keratieos. j Cutan Pathol, 1988；1(15)：8～17

57.MazoujianG, et al. Immunohistochemistry of gross disease fluid protein (GCDFP-15) in 65benign sweat gland tumors of the skin. Am j Dermatopathol, 1988, 1(10)：28～35

58. WoodWS, et al. Mammary Paget’s disease and intraductal carcinoma ：histologic, histologic,histochemical and immunocytochemical comparison. Am j Dermatopathol, 1988,10(3)：188

59.Mihara M. Chondroid syringoma associated with hidrocystoma – like changes ：possible differentiation intoeccring gland：a histologic. immunohistochemical and electron microscopic study. JCutan Pathol, 1989, 5(16)：281～286

60.Penneys NS, et al. Immunohistochemistry demonstration of ferritin in sweatgland and sweat gland neoplasms. J Cutan Pathol, 1990, 1(17)：32～36

61. UranoY, et al. Immunohistochemistry demonstration of petidylarginine deiminase inhuman sweat glands. Am J Dermatopathol, 1990；12(3)：249～255

62.Mazoujian G. Immunohistochemistry of GCDFP –24 and zinic alpha2 glycoprotein inbenign sweat gland tumors. Am J Dermatopathol,1990, 12(5)：452～457